טוען...
Molecular subtyping of leiomyosarcoma with 3′ end RNA sequencing
Leiomyosarcoma (LMS) is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for LMS. We performed expression profiling on 99 cases of LMS with 3′ end RNA sequencing (3SEQ) and demonstrated the existence o...
שמור ב:
| הוצא לאור ב: | Genom Data |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4521214/ https://ncbi.nlm.nih.gov/pubmed/26240788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gdata.2015.06.029 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|